FreeTender
Deadline not statedawardNorway

Development services for minimally invasive glaucoma surgery (MIGS) device

Issued by Inven2 AS · via Doffin — Norwegian Public Procurement

Verify & apply on the official portal →
Published
23 Sept 2026
Value
NOK 3,000,000
Reference
2026-114934
Location
Oslo, Norway
Sector
Healthcare & Pharma

At a glance

Inven2 AS in Norway has published a contract award notice in healthcare & pharma: “Development services for minimally invasive glaucoma surgery (MIGS) device”. The notice does not state a closing date, so confirm the timetable on the official portal. The stated value is NOK 3,000,000. Quote reference 2026-114934 in any correspondence with the buyer. There are 120 open healthcare & pharma notices in Norway on FreeTender. Bids are submitted to the buyer through Doffin — Norwegian Public Procurement, not through FreeTender.

Key requirements

Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.

To bid on EU public procurement

Most EU buyers ask for the European Single Procurement Document (ESPD) as a self-declaration with the bid. Submission is on the e-procurement platform named in the notice.

Details

We are seeking quotes for the development and manufacturing of a multi-lumen stent intended for minimally invasive glaucoma surgery (MIGS). The device is designed to lower intraocular pressure (IOP), a key factor in the progression of glaucoma, with the ability to regulate pressure post insertion.

The development scope, estimated to about 2 years of development, includes optimizing the stent design using in silico modeling, prototyping, and in vitro testing with ocular models and extracted pig eyes. Manufacturing will involve precision techniques such as microscale injection molding and extrusion, ensuring the production of a batch that meets the standards for preclinical testing. Approximately 100 units are planned for manufacturing to support the initial in vitro testing and a preclinical efficacy study in pigs.

Buyer: Inven2 AS

Place of performance: Oslo

Full notice and tender documents are on Doffin (Norwegian).

This notice has closed — what to do next

There are 120 open Healthcare & Pharma tenders in Norway.

Browse all open Healthcare & Pharma tenders →

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

  • Confirm the closing date and submission window on the official portal before you start preparing your bid.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
Common bidding mistakes to avoid →Writing a winning proposal

More Healthcare & Pharma tenders

All Healthcare & Pharma tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →